RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,012,503 | -3.8% | 1,047,386 | -6.0% | 3.06% | -4.9% |
| Q2 2023 | $8,326,256 | +12.0% | 1,114,626 | 0.0% | 3.22% | -0.5% |
| Q1 2023 | $7,434,555 | -13.5% | 1,114,626 | 0.0% | 3.23% | -20.5% |
| Q4 2022 | $8,593,766 | -27.6% | 1,114,626 | -0.1% | 4.07% | -16.1% |
| Q3 2022 | $11,876,000 | +15.1% | 1,116,126 | -11.9% | 4.85% | +18.6% |
| Q2 2022 | $10,317,000 | +13.7% | 1,267,430 | 0.0% | 4.09% | +30.6% |
| Q1 2022 | $9,075,000 | -57.8% | 1,267,430 | +1.0% | 3.13% | -50.9% |
| Q4 2021 | $21,506,000 | – | 1,255,430 | – | 6.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
| MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
| MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
| Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
| ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
| HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
| Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
| Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |